Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares WHO classification of haematolymphoid tumours, fifth edition: myeloid and histiocytic neoplasms, Cladribine, Interferon alfa-2a/2b, Driver mutation and the tags subtype-page, haematologic.
Shares WHO classification of haematolymphoid tumours, fifth edition: myeloid and histiocytic neoplasms, Cladribine, Interferon alfa-2a/2b, Driver mutation and the tags subtype-page, haematologic.
Shares FDG PET, Active surveillance and the tags subtype-page, haematologic.
Shares FDG PET and the tags subtype-page, haematologic.
Shares FDG PET and the tags subtype-page, haematologic.
Shares FDG PET and the tags subtype-page, haematologic.
Shares Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages, Cladribine, Rosai-Dorfman-Destombes disease, BRAF V600E mutation and the tag subtype-page.
Shares ARAF, Cladribine, Multisystem Langerhans cell histiocytosis (with or without risk-organ involvement), Erdheim-Chester disease, Rosai-Dorfman disease and other histiocytic neoplasms and the tag haematologic.
The same record for scripts and assistants; checked 2026-09-18. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.